Overview

• The IPO is entirely an offer-for-sale by existing promoters and investors with no fresh capital raised by the company.
• Anchor investor bidding begins on July 11 ahead of the ₹540–570 per share price band for public subscription from July 14 to 16.
• Allotment is scheduled for July 17 with a targeted listing on BSE and NSE on July 21.
• Anthem posted a 30% rise in FY25 revenue to ₹1,844 crore and a 23% jump in profit after tax to ₹451 crore, bolstering investor interest.
• The company is leveraging global pharma’s shift away from China and plans to commission a third cGMP facility in Karnataka by H1 FY26.